Workflow
融资融券
icon
Search documents
长盛轴承1月16日获融资买入1.02亿元,融资余额7.94亿元
Xin Lang Cai Jing· 2026-01-19 01:43
Group 1 - The core viewpoint of the news is that Changsheng Bearing has shown positive financial performance and trading activity, with a notable increase in stock price and trading volume on January 16 [1] - On January 16, Changsheng Bearing's stock price increased by 2.33%, with a trading volume of 838 million yuan. The net financing purchase on that day was 13.58 million yuan, with a total financing and securities balance of 796 million yuan [1] - As of January 16, the financing balance of Changsheng Bearing was 794 million yuan, accounting for 3.17% of its circulating market value [1] Group 2 - As of September 30, the number of shareholders of Changsheng Bearing increased to 73,000, a rise of 6.5%, while the average circulating shares per person decreased by 6.11% to 2,655 shares [2] - For the period from January to September 2025, Changsheng Bearing achieved an operating income of 935 million yuan, representing a year-on-year growth of 11.97%, and a net profit attributable to the parent company of 188 million yuan, up by 11.01% [2] - Since its A-share listing, Changsheng Bearing has distributed a total of 747 million yuan in dividends, with 394 million yuan distributed in the last three years [3] Group 3 - As of September 30, 2025, among the top ten circulating shareholders of Changsheng Bearing, Hong Kong Central Clearing Limited was the fifth largest shareholder, increasing its holdings by 1.425 million shares to 2.5488 million shares [3] - The Southern CSI 1000 ETF ranked as the eighth largest circulating shareholder, reducing its holdings by 9,600 shares to 1.0922 million shares [3]
索通发展1月16日获融资买入6321.11万元,融资余额7.27亿元
Xin Lang Cai Jing· 2026-01-19 01:43
Group 1 - The core viewpoint of the news is that Sutong Development has experienced fluctuations in its stock performance and financing activities, indicating a complex market situation [1][2]. - On January 16, Sutong Development's stock fell by 1.78%, with a trading volume of 422 million yuan. The net financing buy was negative at 27.82 million yuan, with a total financing and margin balance of 729 million yuan [1]. - The financing balance of Sutong Development is 727 million yuan, accounting for 5.75% of its market capitalization, which is above the 60th percentile level over the past year, indicating a high level of financing activity [1]. Group 2 - As of January 9, the number of shareholders of Sutong Development decreased by 4.09% to 45,100, while the average circulating shares per person increased by 4.26% to 11,047 shares [2]. - For the period from January to September 2025, Sutong Development achieved operating revenue of 12.762 billion yuan, representing a year-on-year growth of 28.66%, and a net profit attributable to shareholders of 654 million yuan, reflecting a significant increase of 201.81% [2]. - Since its A-share listing, Sutong Development has distributed a total of 1.148 billion yuan in dividends, with 629 million yuan distributed in the last three years [3].
永安行1月16日获融资买入1699.75万元,融资余额4.08亿元
Xin Lang Cai Jing· 2026-01-19 01:43
Group 1 - The core business of Yong'anxing Technology Co., Ltd. includes the development, sales, construction, and operation services of shared travel systems based on IoT and big data analysis technology, with revenue contributions from various segments [2] - As of September 30, the number of shareholders of Yong'anxing decreased by 8.08% to 15,200, while the average circulating shares per person increased by 26.65% to 18,426 shares [2] - For the period from January to September 2025, Yong'anxing reported a revenue of 317 million yuan, a year-on-year decrease of 15.23%, and a net profit attributable to the parent company of -69.39 million yuan, a year-on-year decrease of 131.85% [2] Group 2 - On January 16, Yong'anxing's stock price increased by 0.70%, with a trading volume of 85.95 million yuan, and a net financing buy of -2.037 million yuan [1] - The total balance of margin trading for Yong'anxing as of January 16 is 408 million yuan, which accounts for 7.75% of its circulating market value, indicating a high level compared to the past year [1] - The company has cumulatively distributed dividends of 438 million yuan since its A-share listing, with 158 million yuan distributed in the last three years [3]
英搏尔1月16日获融资买入3539.61万元,融资余额4.77亿元
Xin Lang Cai Jing· 2026-01-19 01:40
Core Viewpoint - The company, Yingboer, has shown significant growth in revenue and net profit, indicating strong operational performance and investor interest in the stock. Group 1: Financial Performance - As of January 16, Yingboer reported a financing buy-in amount of 35.40 million yuan, with a net financing buy of 3.62 million yuan, indicating active trading interest [1] - For the period from January to September 2025, Yingboer achieved operating revenue of 2.36 billion yuan, a year-on-year increase of 46.70%, and a net profit attributable to shareholders of 149 million yuan, reflecting a substantial growth of 191.18% [2] Group 2: Shareholder and Market Activity - As of November 10, the number of Yingboer's shareholders increased to 25,600, with an average of 7,313 circulating shares per person, showing a slight increase in shareholder engagement [2] - On January 16, Yingboer's total margin trading balance reached 477 million yuan, accounting for 5.71% of its market capitalization, which is above the 80th percentile of the past year, indicating a high level of leverage [1] Group 3: Shareholding Structure - As of September 30, 2025, the top ten circulating shareholders included notable institutional investors, with changes in holdings reflecting a mix of reductions and new entries among major shareholders [3]
奥翔药业1月16日获融资买入649.80万元,融资余额3.92亿元
Xin Lang Cai Jing· 2026-01-19 01:39
Group 1 - The core viewpoint of the news is that Aoxiang Pharmaceutical experienced a slight decline in stock price and has notable financing activities, indicating a mixed sentiment among investors [1] - On January 16, Aoxiang Pharmaceutical's stock fell by 0.79%, with a trading volume of 75.74 million yuan. The net financing purchase for the day was 574,400 yuan, with a total financing and securities balance of 392 million yuan [1] - The financing balance of Aoxiang Pharmaceutical accounts for 4.72% of its market capitalization, which is above the 70th percentile of the past year, indicating a relatively high level of financing [1] Group 2 - Aoxiang Pharmaceutical, established on April 22, 2010, specializes in the research, production, and sales of specialty APIs and intermediates, with a revenue composition that includes liver disease (31.29%), cardiovascular (18.94%), and antibacterial (18.56%) products [2] - For the period from January to September 2025, Aoxiang Pharmaceutical reported a revenue of 646 million yuan, a year-on-year decrease of 6.40%, and a net profit attributable to shareholders of 207 million yuan, down 9.59% year-on-year [2] - As of September 30, 2025, Aoxiang Pharmaceutical had 32,000 shareholders, an increase of 5.64% from the previous period, with an average of 25,948 circulating shares per person, a decrease of 5.34% [2] Group 3 - Aoxiang Pharmaceutical has distributed a total of 286 million yuan in dividends since its A-share listing, with 207 million yuan distributed over the past three years [3] - As of September 30, 2025, Hong Kong Central Clearing Limited was the ninth largest circulating shareholder of Aoxiang Pharmaceutical, holding 5.36 million shares, an increase of 160,600 shares from the previous period [3]
三孚股份1月16日获融资买入1.10亿元,融资余额1.81亿元
Xin Lang Cai Jing· 2026-01-19 01:39
Group 1 - The core viewpoint of the news highlights the recent performance and financial metrics of Sanfu Co., indicating a significant increase in stock price and trading volume on January 16, with a 4.90% rise and a transaction amount of 1.378 billion yuan [1] - As of January 16, Sanfu Co. had a financing balance of 181 million yuan, which represents 1.75% of its market capitalization, indicating a high level of financing activity compared to the past year [1] - The company specializes in the research, production, and sales of fine chemical products, including trichlorosilane and potassium hydroxide, with its main revenue sources being potassium series (56.54%), silane coupling agents (26.33%), and silicon series (14.39%) [1] Group 2 - As of September 30, the number of shareholders for Sanfu Co. was 22,300, a decrease of 10% from the previous period, while the average circulating shares per person increased by 11.11% to 17,162 shares [2] - For the period from January to September 2025, Sanfu Co. achieved an operating income of 1.548 billion yuan, reflecting a year-on-year growth of 15.20%, and a net profit attributable to shareholders of 64.136 million yuan, up 26.92% year-on-year [2] - The company has distributed a total of 224 million yuan in dividends since its A-share listing, with 102 million yuan distributed over the past three years [2]
秦港股份1月16日获融资买入1119.22万元,融资余额1.56亿元
Xin Lang Cai Jing· 2026-01-19 01:39
Group 1 - The core business of Qinhuangdao Port Co., Ltd. includes integrated port services such as loading, storage, warehousing, transportation, and logistics, with coal and related products accounting for 66.61% of revenue [2] - As of September 30, the company reported a revenue of 5.212 billion yuan, representing a year-on-year growth of 2.81%, and a net profit attributable to shareholders of 1.391 billion yuan, up 3.87% year-on-year [2] - The company has distributed a total of 3.565 billion yuan in dividends since its A-share listing, with 1.335 billion yuan distributed over the past three years [3] Group 2 - On January 16, Qinhuangdao Port's stock price remained unchanged, with a trading volume of 82.7954 million yuan [1] - The financing buy-in amount on January 16 was 11.1922 million yuan, with a net financing buy of 0.9579 million yuan, while the total financing and securities balance reached 1.56 billion yuan [1] - The company’s margin trading balance is at 0.95% of its market capitalization, indicating a high level of financing activity, while the short selling balance is at a low level, below the 30th percentile of the past year [1]
新劲刚1月16日获融资买入7768.53万元,融资余额6.77亿元
Xin Lang Cai Jing· 2026-01-19 01:36
Core Viewpoint - The company, New Jingang, is experiencing significant financial challenges, with a notable decline in revenue and net profit, alongside high financing and margin trading levels, indicating potential liquidity concerns and investor sentiment shifts [1][2][3]. Group 1: Financial Performance - As of January 16, New Jingang's stock price decreased by 2.48%, with a trading volume of 734 million yuan [1]. - For the period from January to September 2025, New Jingang reported a revenue of 270 million yuan, representing a year-on-year decrease of 33.18% [2]. - The company's net profit attributable to shareholders was 11.23 million yuan, reflecting a significant year-on-year decline of 90.04% [2]. Group 2: Financing and Margin Trading - On January 16, New Jingang had a financing buy-in amount of 77.69 million yuan, with a net financing outflow of 6.19 million yuan [1]. - The total financing and margin trading balance reached 677 million yuan, accounting for 9.78% of the circulating market value, which is above the 90th percentile of the past year [1]. - The company had a margin trading balance of 321,900 yuan, with a margin trading volume of 11,700 shares, also exceeding the 90th percentile of the past year [1]. Group 3: Shareholder and Dividend Information - New Jingang has distributed a total of 103 million yuan in dividends since its A-share listing, with 68.08 million yuan distributed over the past three years [3]. - As of September 30, 2025, the number of shareholders decreased to 23,400, a reduction of 0.49% from the previous period [2]. - The average number of circulating shares per shareholder increased by 0.49% to 9,260 shares [2].
金溢科技1月16日获融资买入1481.62万元,融资余额2.36亿元
Xin Lang Cai Jing· 2026-01-19 01:36
Core Viewpoint - Jinli Technology's stock performance shows a mixed trend with a slight increase in price but a significant net outflow in financing activities, indicating potential investor concerns about the company's financial health and future prospects [1][2]. Financing Summary - On January 16, Jinli Technology's financing buy-in amounted to 14.82 million yuan, while financing repayment reached 32.84 million yuan, resulting in a net financing outflow of 18.03 million yuan [1]. - The total financing and securities balance for Jinli Technology as of January 16 is 236 million yuan, which constitutes 5.31% of its circulating market value, indicating a relatively high level of financing activity compared to the past year [1]. - The company has a high short-selling position, with a short-selling balance of 82,900 yuan and a short-selling volume of 600 shares on January 16, reflecting increased bearish sentiment among investors [1]. Company Performance Summary - As of September 30, Jinli Technology reported a total of 22,300 shareholders, a decrease of 36.16% from the previous period, while the average circulating shares per person increased by 58.43% to 7,153 shares [2]. - For the period from January to September 2025, Jinli Technology achieved a revenue of 327 million yuan, representing a year-on-year decrease of 7.12%, and reported a net loss attributable to shareholders of 29.61 million yuan, a significant decline of 195.25% compared to the previous year [2]. Dividend and Shareholding Summary - Since its A-share listing, Jinli Technology has distributed a total of 583 million yuan in dividends, with 62.49 million yuan distributed over the past three years [3]. - As of September 30, 2025, among the top ten circulating shareholders, Huaxia Industry Prosperity Mixed Fund (003567) is the third-largest shareholder with 3.72 million shares, while Hong Kong Central Clearing Limited is the seventh-largest with 2.79 million shares, having increased its holdings by 1.98 million shares [3].
长川科技1月16日获融资买入9.15亿元,融资余额30.54亿元
Xin Lang Cai Jing· 2026-01-19 01:36
Group 1 - The core viewpoint of the news is that Changchuan Technology has shown significant financial growth, with a notable increase in revenue and net profit for the period ending September 2025 [2] - As of January 16, Changchuan Technology's stock price increased by 0.87%, with a trading volume of 7.037 billion yuan, indicating strong market interest [1] - The company has a high financing balance of 30.54 billion yuan, which accounts for 3.48% of its circulating market value, placing it in the top 90% percentile over the past year [1] Group 2 - For the period from January to September 2025, Changchuan Technology achieved a revenue of 3.779 billion yuan, representing a year-on-year growth of 49.05% [2] - The net profit attributable to the parent company for the same period was 865 million yuan, reflecting a substantial year-on-year increase of 142.14% [2] - The company has distributed a total of 305 million yuan in dividends since its A-share listing, with 187 million yuan distributed over the past three years [2]